Subdiaphragmatic vagal deafferentation fails to block feeding-suppressive effects of LPS and IL-1 beta in rats

被引:63
作者
Schwartz, GJ
PlataSalaman, CR
Langhans, W
机构
[1] UNIV DELAWARE, SCH LIFE & HLTH SCI, NEWARK, DE 19716 USA
[2] SWISS FED INST TECHNOL, INST ANIM SCI, CH-8092 ZURICH, SWITZERLAND
关键词
cytokine; endotoxin; food intake; ingestion; vagus; visceral afferents;
D O I
10.1152/ajpregu.1997.273.3.R1193
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
To evaluate the role of subdiaphragmatic vagal afferent fibers in mediating the inhibition of food intake produced by peripheral administration of bacterial lipopolysaccharide (LPS) and the proinflammatory cytokine interleukin-1 beta (IL-1 beta), we assessed the ability of 100 mu g/kg ip LPS and 2 mu g/kg ip human recombinant IL-1 beta to suppress solid food intake during the first 3 and 6 h of the dark cycle in rats with selective vagal rootlet deafferentation (SDA, n = 15) and in sham surgical control rats (Con, n = 17). SDA was produced by a combination of dorsal subdiaphragmatic truncal vagotomy and left vagal afferent rootlet transection as the left vagus enters the caudal brain stem. Both LPS and IL-1 beta significantly suppressed food intake at 3 and 6 h in both Con and SDA rats, and SDA failed to attenuate the LPS-and IL-1 beta-induced reductions in food consumption relative to the suppression seen in controls. Peripheral administration of the gut-brain peptide cholecystokinin (CCK) suppressed 30-min 12.5% liquid glucose consumption in control, but not in SDA rats, consistent with previous demonstrations of the role of subdiaphragmatic vagal afferents in the mediation of CCK satiety. These data demonstrate that subdiaphragmatic vagal afferents are not necessary for the feeding-suppressive actions of peripherally administered LPS and IL-1 beta and suggest that peripheral LPS and IL-1 beta may inhibit food intake via humoral and/or splanchnic visceral afferent pathways.
引用
收藏
页码:R1193 / R1198
页数:6
相关论文
共 33 条
[1]  
Ban E M, 1994, Immunomethods, V5, P31, DOI 10.1006/immu.1994.1035
[2]   INTERLEUKIN-1-ALPHA IN BLOOD HAS DIRECT ACCESS TO CORTICAL BRAIN-CELLS [J].
BANKS, WA ;
KASTIN, AJ ;
GUTIERREZ, EG .
NEUROSCIENCE LETTERS, 1993, 163 (01) :41-44
[3]   Vagotomy blocks behavioural effects of interleukin-1 injected via the intraperitoneal route but not via other systemic routes [J].
Bluthe, RM ;
Michaud, B ;
Kelley, KW ;
Dantzer, R .
NEUROREPORT, 1996, 7 (15-17) :2823-2827
[4]   DIFFERENTIAL-EFFECTS OF IL-1RA ON SICKNESS BEHAVIOR AND WEIGHT-LOSS INDUCED BY IL-1 IN RATS [J].
BLUTHE, RM ;
BEAUDU, C ;
KELLEY, KW ;
DANTZER, R .
BRAIN RESEARCH, 1995, 677 (01) :171-176
[5]   Systemic capsaicin pretreatment fails to block the decrease in food-motivated behavior induced by lipopolysaccharide and interleukin-1 beta [J].
BretDibat, JL ;
Creminon, C ;
Couraud, JY ;
Kelley, KW ;
Dantzer, R ;
Kent, S .
BRAIN RESEARCH BULLETIN, 1997, 42 (06) :443-449
[6]   LIPOPOLYSACCHARIDE AND INTERLEUKIN-1 DEPRESS FOOD-MOTIVATED BEHAVIOR IN MICE BY A VAGAL-MEDIATED MECHANISM [J].
BRETDIBAT, JL ;
BLUTHE, RM ;
KENT, S ;
KELLEY, KW ;
DANTZER, R .
BRAIN BEHAVIOR AND IMMUNITY, 1995, 9 (03) :242-246
[7]   INDUCTION BY LIPOPOLYSACCHARIDE OF CYCLOOXYGENASE-2 MESSENGER-RNA IN FAT BRAIN - ITS POSSIBLE ROLE IN THE FEBRILE RESPONSE [J].
CAO, CY ;
MATSUMURA, K ;
YAMAGATA, K ;
WATANABE, Y .
BRAIN RESEARCH, 1995, 697 (1-2) :187-196
[8]   Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1 beta: A possible site of prostaglandin synthesis responsible for fever [J].
Cao, CY ;
Matsumura, K ;
Yamagata, K ;
Watanabe, Y .
BRAIN RESEARCH, 1996, 733 (02) :263-272
[9]   TYPE-1 INTERLEUKIN-1 RECEPTOR IN THE RAT-BRAIN - DISTRIBUTION, REGULATION, AND RELATIONSHIP TO SITES OF IL-1-INDUCED CELLULAR ACTIVATION [J].
ERICSSON, A ;
LIU, C ;
HART, RP ;
SAWCHENKO, PE .
JOURNAL OF COMPARATIVE NEUROLOGY, 1995, 361 (04) :681-698
[10]   EXPRESSION OF INTERLEUKIN-1-ALPHA, INTERLEUKIN-1-BETA AND INTERLEUKIN-1 RECEPTOR ANTAGONIST MESSENGER-RNA IN MOUSE-BRAIN - REGULATION BY BACTERIAL LIPOPOLYSACCHARIDE (LPS) TREATMENT [J].
GABELLEC, MM ;
GRIFFAIS, R ;
FILLION, G ;
HAOUR, F .
MOLECULAR BRAIN RESEARCH, 1995, 31 (1-2) :122-130